Fagron Concepts

Fagron UK supples gelatin and vegetarian Capsugel capsules of various sizes in packs of 500 or 1000.
SyrSpend® SF PH4 is Fagron's innovative oral suspension vehicle, compatible with a wide range of API's and superior to traditional suspension vehicles
Leading advanced dermatological care

ESPUMIL™

Espumil™ is an innovative, lipophilic foam base where the foam is generated by foam-activating packaging. The unique delivery features of Espumil™ assure the simple application of lipophilic active pharmaceutical ingredients (APIs) on difficult-to-treat areas such as hairy skin and the scalp, without dripping. This product is free of fragrances, dyes, parabens, mineral oil, SLS and 1,4-dioxane and is gently preserved.

Benefits of ESPUMIL™

  • Innovative base solution for easy compounding of foams
  • Creamy foam formula with minimal greasiness
  • Light skin feel, drip-free
  • Gentle formula without gaseous propellants; the foam is activated by Fagron’s foam activating pumps
  • Especially suitable for application on difficult-to-treat areas, such as hairy skin and the scalp
  • Compatible with lipophilic APIs and DCIs, such as Minoxidil
  • Simple three-step compounding process
ESPUMIL™

You are now being redirected to the Fagron shop.

Benefits of ESPUMIL™

  • Innovative base solution for easy compounding of foams
  • Creamy foam formula with minimal greasiness
  • Light skin feel, drip-free
  • Gentle formula without gaseous propellants; the foam is activated by Fagron’s foam activating pumps
  • Especially suitable for application on difficult-to-treat areas, such as hairy skin and the scalp
  • Compatible with lipophilic APIs and DCIs, such as Minoxidil
  • Simple three-step compounding process

Product information

Technical data
Ingredients
Purified water, alcohol, humectant, acidifying agent, emulsifier, foaming agent, antioxidant.
Appearance
Clear solution.
Odor
Mostly odourless.
pH
1.5-3.5.
Shelf life unopened
24 months.
Shelf life opened
12 months.
Storage conditions
Store below 25°C.
All ingredients have been generally recognised as safe by the USFDA, ANVISA and the Regulation (EC) No 1907/2006 (REACH) when used in accordance with their intended purposes.